The effect of macrophage sphingomyelin synthase (SMS) on atherosclerosis
The effect of macrophage sphingomyelin synthase (SMS) on atherosclerosis
批准号:
7649753
负责人:
XIAN-CHENG JIANG
金额:
$42.34万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2011-08-31
关键词:
1,2-diacylglycerolAdenovirusesAnabolismAnimalsAntiatherogenicApoptosisApoptoticArterial Fatty StreakArteriesAtherosclerosisAttenuatedBindingBone Marrow TransplantationCell membraneCell physiologyCeramidesCholesterolCholesterol HomeostasisCollagenCoronary heart diseaseDepositionDeveloped CountriesDeveloping CountriesDevelopmentDietDiglyceridesDiseaseElastinEndosomesEventFoam CellsGenesHydrolysisInflammationInflammatoryInflammatory ResponseInterleukin-6Knock-outKnockout MiceLDL Cholesterol LipoproteinsLaboratoriesLecithinLesionLinkLipidsLipopolysaccharidesLow Density Lipoprotein ReceptorLysosomesMAP Kinase Signaling PathwaysMediatingMembrane LipidsMembrane MicrodomainsMembrane Structure and FunctionMitogen-Activated Protein KinasesMusNF-kappa BNecrosisPathway interactionsPlayPredictive ValueProcessProductionProtein IsoformsRelative (related person)Risk FactorsRoleSignal TransductionSiteSmall Interfering RNASmooth Muscle MyocytesSphingomyelinaseSphingomyelinsSystemT-LymphocyteTestingWorkatherogenesisbasecell typechemokinecholesterol traffickingcytokineinnovationknockout animalknockout genemacrophagemortalitymouse modelnovelnovel strategiesoverexpressionpreventpublic health relevanceresearch studyreverse cholesterol transportsphingomyelin synthasesuccesstherapeutic targettool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Macrophages are the most prominent cell type in atherosclerotic lesions, and are associated with three hallmarks of the disease:lipid deposition, inflammation, and macrophage-derived foam cell disordered apoptosis. The ability to regulate SMS activity could become a promising approach for regulating these macrophage functions, thus influencing the atherosclerosis. SMS utilizes ceramide and phosphatidylcholine (PC) as substrates to produce sphingomyelin (SM) and diacylglycerol. SM is one of the major lipid components of cell membranes, including macrophages. SM-enriched lipid rafts in these plasma membranes provide a platform for many important cellular processes, such as cholesterol efflux and signal transduction. The SMS activity-related events listed above may well have an impact on the development of atherosclerosis. SMS has two isoforms: SMS1 and SMS2. We have evidence demonstrating that SMS activity is closely related to macrophage plasma membrane structure and function. Such findings emphasize the need for better understanding of these SMS functions in our exploration of the relationship between macrophage SMS (SMS1 and SMS2) and atherosclerosis. We now hypothesize that both SMS1 and -2 deficiencies decrease macrophage SM levels, promote cholesterol efflux, diminish the production of inflammatory cytokines and chemokines, and reduce apoptosis. They thus prevent the development of atherosclerosis, while SMS1 and -2 overproduction have the opposite effect. The major focus of this project will be to manipulate SMS activity using SMS1 and -2 gene knockout or over expression approaches to manipulate SM levels. It should be mentioned that the gene knockout mice and adenovirus-mediated expression system necessary for this work are already available in our laboratory. Our Specific Aims are to: 1) determine the role of SMS1 and SMS2 deficiencies in macrophage cholesterol efflux, 2) explore the impact of SMS1 and -2 deficiencies and over expression on inflammatory response and apoptosis in macrophages, and 3) investigate the role of macrophage SMS1 and -2 deficiencies in atherosclerosis. Success with this proposal will help us elucidate the distinctive functions of macrophage SMS relative to atherosclerosis, determine the differences and similarities between macrophage SMS1 and macrophage SMS2 in the process of atherosclerosis, and evaluate SMS as a therapeutic target for treatment of it. PUBLIC HEALTH RELEVANCE: The success of this proposal will help us to elucidate the distinctive function of macrophage SMS relative to atherosclerosis; disclose the difference and similarity between macrophage SMS1 and SMS2, in the process of atherosclerosis; and evaluate SMS as a therapeutic target for atherosclerosis treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of sphingomyelin biosynthesis on atherosclerosis
-
批准号:10320422
-
项目类别:
-
资助金额:$47.75万
-
财政年份:2020
-
负责人:XIAN-CHENG JIANG
-
依托单位:
Effect of sphingomyelin biosynthesis on atherosclerosis
-
批准号:10543518
-
项目类别:
-
资助金额:$48.67万
-
财政年份:2020
-
负责人:XIAN-CHENG JIANG
-
依托单位:
Effects of PC remodeling on macrophages and adipocytes: its relevance to atherosclerosis
-
批准号:9914073
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2018
-
负责人:XIAN-CHENG JIANG
-
依托单位:
Hepatic PLTP as a target for lowering LDL-c
-
批准号:8916209
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Effect of SPT Deficiency on Atherosclerosis
-
批准号:8391620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
PLTP as a target for lowering VLDL production
-
批准号:9269453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
Effect of SMSr on VLDL metabolism and atherosclerosis
-
批准号:10252097
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
Effect of SMSr on VLDL metabolism and atherosclerosis
-
批准号:10512745
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Effect of SPT Deficiency on Atherosclerosis
-
批准号:8141628
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Effect of SPT Deficiency on Atherosclerosis
-
批准号:8598001
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
PLTP as a target for lowering VLDL production
-
批准号:9129936
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The effect of macrophage sphingomyelin synthase (SMS) on atherosclerosis
-
批准号:7860583
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2009
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis
-
批准号:7784430
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis
-
批准号:7585278
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The role of PLTP in BLp metabolism and atherogenesis
-
批准号:6622791
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The role of PLTP in BLp metabolism and atherogenesis
-
批准号:6849327
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis
-
批准号:7408075
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The role of PLTP in BLp metabolism and atherogenesis
-
批准号:6455674
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The Role of Plasma Phospholipid Transfer Protein in Atherosclerosis
-
批准号:7255084
-
项目类别:
-
资助金额:$35.03万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
The role of PLTP in BLp metabolism and atherogenesis
-
批准号:6727529
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:XIAN-CHENG JIANG
-
依托单位:
海外基金